NCT02263066 Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis Status COMPLETED Phase N/A
NCT02262676 Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain Status COMPLETED Phase N/A
NCT02262663 Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of Vilaprisan Status COMPLETED Phase PHASE1
NCT02260687 Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Status COMPLETED Phase N/A
NCT02258464 Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT02258451 Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02253420 COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients Status COMPLETED Phase PHASE1
NCT02248610 Follow-up in Rivaroxaban Patients in Setting of Thromboembolism Status COMPLETED Phase N/A
NCT02247310 BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon Status COMPLETED Phase N/A
NCT02246686 Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients Status TERMINATED Phase PHASE2
NCT02237534 Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia Status UNKNOWN Phase PHASE4
NCT02234843 EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis Status COMPLETED Phase PHASE3
NCT02222207 Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration Status TERMINATED Phase PHASE2
NCT02212080 First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784 Status COMPLETED Phase PHASE1
NCT02210819 Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy Status COMPLETED Phase N/A
NCT02204943 Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02200614 Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT02196857 Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation Status COMPLETED Phase PHASE2